Origin Life Sciences, Inc. (OLSI)
Origin Life Sciences will go public soon, but the exact IPO date is still unknown.
IPO Price
$4.00
Shares Offered
1,875,000
Deal Size
$7.50M
Origin Life Sciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
78.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOLSI News
- 7 months ago - Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection - GlobeNewsWire
- 2 years ago - U.S. IPO Weekly Recap: 2 Small Deals Begin Trading As Big IPOs Wait In The Wings - Seeking Alpha
- 2 years ago - Origin Life Sciences Aims For $15 Million U.S. IPO - Seeking Alpha
- 2 years ago - Medical device developer Origin Life Sciences files and sets terms for a $15 million IPO - Renaissance Capital
- 2 years ago - Origin Life Sciences IPO Registration Document (S-1) - SEC